Index - P/E - EPS (ttm) -0.52 Insider Own 52.59% Shs Outstand 126.31M Perf Week 10.47%
Market Cap 97.81M Forward P/E - EPS next Y -0.66 Insider Trans 0.49% Shs Float 59.68M Perf Month 7.29%
Enterprise Value -21.88M PEG - EPS next Q -0.15 Inst Own 27.29% Short Float 0.38% Perf Quarter 10.47%
Income -65.69M P/S - EPS this Y -1.79% Inst Trans -13.50% Short Ratio 0.68 Perf Half Y -30.23%
Sales 0.00M P/B 0.54 EPS next Y -15.79% ROA -27.03% Short Interest 0.23M Perf YTD -53.90%
Book/sh 1.43 P/C 0.66 EPS next 5Y -4.00% ROE -31.55% 52W High 3.09 -74.94% Perf Year -71.84%
Cash/sh 1.17 P/FCF - EPS past 3/5Y 1.79% -4.55% ROIC -32.03% 52W Low 0.62 24.90% Perf 3Y -64.48%
Dividend Est. - EV/EBITDA - Sales past 3/5Y - - Gross Margin - Volatility 8.06% 6.36% Perf 5Y -92.78%
Dividend TTM - EV/Sales - EPS Y/Y TTM 6.27% Oper. Margin - ATR (14) 0.05 Perf 10Y -
Dividend Ex-Date - Quick Ratio 18.52 Sales Y/Y TTM - Profit Margin - RSI (14) 62.73 Recom 1.00
Dividend Gr. 3/5Y - - Current Ratio 18.52 EPS Q/Q 17.12% SMA20 11.87% Beta 1.29 Target Price 2.50
Payout - Debt/Eq 0.16 Sales Q/Q - SMA50 6.47% Rel Volume 1.08 Prev Close 0.72
Employees 155 LT Debt/Eq 0.13 Earnings Jul 31 BMO SMA200 -30.98% Avg Volume 329.37K Price 0.77
IPO Aug 07, 2020 Option/Short Yes / Yes EPS/Sales Surpr. 22.58% -Trades
Volume 357,353 Change 7.45%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-05-24 Downgrade Goldman
Neutral → Sell
$1.75
Jun-27-24 Initiated Guggenheim
Buy
$6
Jun-03-24 Resumed Jefferies
Hold
$3
Jan-06-22 Initiated Morgan Stanley
Equal-Weight
$8
Nov-02-21 Initiated Cowen
Outperform
Aug-04-21 Initiated Goldman
Neutral
$10
Jul-13-21 Initiated Jefferies
Buy
$13
Aug-27-25 08:00AM
Jul-31-25 08:00AM
Jul-30-25 08:00AM
Jul-15-25 08:00AM
May-27-25 08:00AM
03:10AM
Loading…
Apr-30-25 03:10AM
Apr-29-25 01:01PM
08:00AM
Apr-16-25 08:00AM
Feb-28-25 02:16AM
Feb-27-25 08:00AM
Feb-18-25 08:00AM
Feb-06-25 08:00AM
Oct-31-24 08:00AM
Oct-30-24 08:00AM
03:07AM
Loading…
03:07AM
Oct-29-24 08:00AM
Oct-08-24 08:00AM
Sep-17-24 08:00AM
Aug-14-24 08:00AM
Jul-30-24 08:00AM
Jul-09-24 08:00AM
May-23-24 08:00AM
May-03-24 12:00PM
May-01-24 11:11AM
03:08AM
Apr-30-24 11:54AM
08:00AM
07:36AM
Apr-11-24 08:00AM
08:00AM
Loading…
Feb-28-24 08:00AM
07:36AM
Feb-22-24 08:00AM
Feb-07-24 08:00AM
Nov-30-23 08:00AM
Nov-01-23 08:05AM
Oct-31-23 08:05AM
Oct-11-23 08:05AM
Sep-06-23 07:30AM
Aug-04-23 08:00AM
Aug-02-23 07:30AM
Jul-11-23 09:23AM
May-24-23 08:05AM
May-02-23 06:30AM
Apr-18-23 04:05PM
Mar-23-23 08:00AM
Mar-07-23 08:00AM
Feb-23-23 06:05AM
Feb-21-23 08:00AM
Jan-26-23 08:00AM
07:45AM
Jan-19-23 08:00AM
Nov-16-22 08:00AM
Nov-01-22 06:05AM
Oct-05-22 08:00AM
Sep-23-22 08:00AM
Sep-01-22 08:00AM
Aug-30-22 08:00AM
Aug-11-22 06:30AM
Aug-02-22 06:48AM
Aug-01-22 04:05PM
Jul-13-22 08:00AM
May-12-22 06:28AM
May-03-22 06:00AM
Apr-12-22 08:00AM
Apr-07-22 08:00AM
Apr-04-22 08:00AM
Mar-31-22 04:05PM
Mar-05-22 07:22AM
Feb-24-22 06:00AM
Feb-16-22 04:05PM
Feb-02-22 01:38PM
Jan-27-22 08:00AM
Dec-16-21 01:07PM
(American City Business Journals)
Dec-05-21 06:39AM
Nov-02-21 08:00AM
06:00AM
Oct-11-21 08:00AM
Sep-10-21 10:21AM
Sep-03-21 09:00AM
Aug-10-21 06:00AM
Aug-09-21 08:00AM
Jul-13-21 08:00AM
Jun-17-21 07:00AM
Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal M. Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Patel Sujal M CEO, President, and Secretary Sep 05 '25 Buy 0.67 116,500 78,544 10,258,221 Sep 09 04:42 PM Patel Sujal M CEO, President, and Secretary Sep 08 '25 Buy 0.68 83,500 57,031 10,341,721 Sep 09 04:42 PM Murphy Matthew B. General Counsel Sep 04 '25 Buy 0.64 20,000 12,858 74,140 Sep 05 06:34 PM Mowry Anna CFO and Treasurer May 29 '25 Buy 0.77 15,000 11,488 83,000 Jun 02 05:12 PM Mallick Parag Chief Scientist May 08 '25 Buy 0.73 12,000 8,788 20,491,892 May 12 07:19 PM Mallick Parag Chief Scientist May 12 '25 Buy 0.73 1,500 1,098 20,493,392 May 12 07:19 PM Patel Sujal M CEO, President, and Secretary Mar 19 '25 Buy 0.99 53,300 53,028 10,117,788 Mar 21 04:44 PM Patel Sujal M CEO, President, and Secretary Mar 20 '25 Buy 1.00 23,933 23,890 10,141,721 Mar 21 04:44 PM MARY GODWIN Officer Dec 17 '24 Proposed Sale 1.94 38,337 74,263 Dec 17 05:21 PM MARY GODWIN Officer Dec 09 '24 Proposed Sale 2.13 35,000 74,588 Dec 09 04:28 PM MARY GODWIN Officer Dec 03 '24 Proposed Sale 2.20 60,000 131,778 Dec 03 04:28 PM MARY GODWIN Officer Nov 26 '24 Proposed Sale 2.28 60,000 136,512 Nov 26 04:31 PM MARY GODWIN Officer Nov 21 '24 Proposed Sale 2.35 30,000 70,623 Nov 21 05:28 PM MARY GODWIN Officer Nov 19 '24 Proposed Sale 2.27 30,000 68,046 Nov 19 05:00 PM MARY GODWIN Officer Nov 11 '24 Proposed Sale 2.47 40,000 98,884 Nov 12 11:38 AM MARY ELIZABETH GODWIN Officer Nov 08 '24 Proposed Sale 2.51 31,078 78,158 Nov 08 04:37 PM MARY ELIZABETH GODWIN Officer Nov 07 '24 Proposed Sale 2.75 28,922 79,643 Nov 07 04:25 PM Godwin Mary E. Senior VP, Operations Sep 23 '24 Option Exercise 0.46 47,031 21,634 47,031 Sep 25 06:29 PM Godwin Mary E. Senior VP, Operations Sep 23 '24 Sale 2.87 47,031 134,744 0 Sep 25 06:29 PM MARY ELIZABETH GODWIN Officer Sep 23 '24 Proposed Sale 2.86 47,031 134,739 Sep 23 04:58 PM Godwin Mary E. Senior VP, Operations Sep 17 '24 Option Exercise 0.46 35,000 16,100 35,000 Sep 18 06:32 PM Godwin Mary E. Senior VP, Operations Sep 17 '24 Sale 2.85 35,000 99,869 0 Sep 18 06:32 PM MARY ELIZABETH GODWIN Officer Sep 17 '24 Proposed Sale 2.85 35,000 99,866 Sep 17 04:22 PM
